Skip to content

Atopic dermatitis and paediatrics in homoeopathy

To assess the effectiveness of constitutional homoeopathic treatment in case of atopic dermatitis in paediatric age group:a pre test post test interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106206
Enrollment
38
Registered
2026-03-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: constitutional homoeopathic medicine: Administering indicated homoeopathic medicine as appropriate to the case for a period of 3 months, medicine will be dispensed in centesimal potency
dosage and repetition will depend upon the individual requirement of the case. Control Intervention1: Nil: Nil

Sponsors

National Institute of Homoeopathy sector A-5 Choudhary ramdev chowk narela Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participant fulfilling Hanifin and Rajka diagnostic criteria. 2. Participants belonging to mild, moderate and severe category of SCORAD Index. 3. Participants parents willing to give written informed consent and the patients willing to give verbal assent (children aged between 7-12 years) and or written assent (children aged between 12-17years). 4. Participants in the age group of 4-17 years. 5. Participants of all genders. 6. Participant already undergoing oral/topical conventional therapy for atopic dermatitis may be recruited after a washout period of 15 days.

Exclusion criteria

Exclusion criteria: 1. Complicated cases of atopic dermatitis like severe secondary infections. 2. Critically ill patient, immune-compromised patient. 3. Patient suffering from any other uncontrolled systemic diseases. 4. Diagnosed cases of unstable mental or psychiatric illness. 5. Patient having any substance abuse.

Design outcomes

Primary

MeasureTime frame
Scoring for Atopic Dermatitis (SCORAD) indexTimepoint: Accessed at baseline and after 3 months.

Secondary

MeasureTime frame
Children s Dermatological Life Quality Index (CDLQI)Timepoint: Accessed at baseline and after 3 months.;MODIFIED NARANJO CRITERIA FOR HOMOEOPATHY (MONARCH)Timepoint: Measured after 3 months of follow up

Countries

India

Contacts

Public ContactDr Vignesh kumar S

National Institute of Homoeopathy delhi

lancevignesh@gmail.com8754779061

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026